Activity
colorectal cancer, SD
DISEASE, COLORECTAL CANCER
Thirteen patients were able to undergo assessment for disease response. The best response observed was SD (> 56 days) in 4 patients, all of whom had colorectal cancer (Fig. RECIST response and time on study All 4 patients with SD after at least 4 doses of NEO-201 elected to continue receiving therapy, range of 1–11 additional doses (Fig. 